Pyrrolopyrimidinones and pyrroloimidazolones and their compositions and
therapeutic methods
    3.
    发明授权
    Pyrrolopyrimidinones and pyrroloimidazolones and their compositions and therapeutic methods 失效
    吡咯并嘧啶酮和吡咯并咪唑酮及其组成和治疗方法

    公开(公告)号:US4325954A

    公开(公告)日:1982-04-20

    申请号:US117482

    申请日:1980-02-01

    摘要: The present invention relates to compounds having the formula: ##STR1## in which: n is equal to 1 or 2,R.sub.1 represents a hydrogen atom and R.sub.2 represents a phenyl group or a benzofuryl group; or R.sub.2 represents a hydrogen atom and R.sub.1 represents a phenyl group or a benzyl group; andgrouping -A-B- represents a group of the formula: ##STR2## or --CO--(CH.sub.2).sub.3 --in which R represents a hydrogen atom, a C.sub.1-6 alkyl radical, a phenyl group, a benzyl group, a methylthioethyl group, or a group having the formula --(CH.sub.2).sub.m --COOR' in which m is equal to 0, 1 or 2 and R' is a C.sub.1-6 alkyl radical,and their pharmacologically acceptable acid addition salts.These compounds are useful in the treatment of depressions.

    摘要翻译: 本发明涉及具有下式的化合物:其中n等于1或2,R1代表氢原子,R2代表苯基或苯并呋喃基; 或R 2表示氢原子,R 1表示苯基或苄基; 并且分组-AB-表示下式的基团:其中R表示氢原子,C 1-6烷基,苯基,苄基,甲硫基乙基,或者-CO-(CH 2)3) 或具有式 - (CH 2)m -COOR'的基团,其中m等于0,1或2,R'为C 1-6烷基,以及它们的药理学上可接受的酸加成盐。 这些化合物可用于治疗凹陷。